Back

The difference of benefit of tolvaptan for acute decompensated heart failure within different etiologies

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Acute heart failure Acute heart failure (therapy) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Yoriyasu Suzuki

Aichi Medical University, Nagakute-cho (Japan)

39 More presentations in this session

Presentation thumbnail
East Asia has a strikingly better survival following acute heart failure compared with Europe
Mr E. Akiyama (Saitama, JP)
Abstract
Presentation thumbnail
Comorbidities more than reduced left ventricular ejection fraction correlates with mortality in heart failure patients discharged from internal medicine units
Doctor V. Verdiani (Grosseto, IT)
Presentation thumbnail
Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction
Professor Y. Takeishi (Fukushima, JP)
Abstract
Presentation thumbnail
Incidence and predictors of hyperkalaemia in 1600 patients with chronic heart failure
Doctor K. Kharbouche (casablanca, MA)
Presentation thumbnail
In patients with recent ADHF and hyponatremia on admission, failure to normalize serum sodium is associated with increased risk of all-cause death and rehospitalizations during a 30-day follow-up
Mrs C. Ariano (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Acute heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources